MRX · Marex Group Ltd · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-17 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on August 15, 2026. The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
100 |
| 2026-11-17 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on August 15, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.212 to $70.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
1,853 |
| 2026-11-17 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on August 15, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $66.14 to $67.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
4,962 |
| 2026-11-17 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on August 15, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.20 to $68.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
5,313 |
| 2026-11-17 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on August 15, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.145 to $69.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
4,004 |
| 2026-11-13 | Sorenson Kory Beth |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The number of ordinary shares reported herein consists of 1,065 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
1,065 |
| 2026-11-09 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.175 to $68.1625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
3,196 |
| 2026-11-09 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.1775 to $69.1725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
10,760 |
| 2026-11-09 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.175 to $69.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
2,712 |
| 2026-11-05 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.17 to $69.0375 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
3,101 |
| 2026-11-05 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.17 to $66.155 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
6,215 |
| 2026-11-05 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.17 to $65.16 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
6,422 |
| 2026-11-05 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.2075 to $68.13 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
2,046 |
| 2026-11-05 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $66.1725 to $67.165 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
4,451 |
| 2026-11-05 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.24 to $69.61 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 272,659 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
221 |
| 2026-10-12 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.35 to $72.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
14,012 |
| 2026-10-12 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026 The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $72.355 to $72.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes (i) 20,367 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 272,659 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
1,260 |
| 2026-10-12 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.39 to $72.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
15,506 |
| 2026-10-12 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $72.42 to $72.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes (i) 20,628 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
1,160 |
| 2026-09-14 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.23 to $71.6 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 272,659 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
2,655 |
| 2026-09-14 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.21 to $71.6, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
2,952 |
| 2026-09-14 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.21 to $71.2075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
13,714 |
| 2026-09-14 | Van Den Born Simon |
President |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.23 to $71.225 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
12,616 |
| 2026-09-07 | Van Den Born Simon |
President |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents the number of ordinary shares withheld to satisfy the tax withholding obligation in connection with the vesting of shares underlying the Issuer's 2022 Annual Long Term Incentive Plan. The price reported represents the closing price of the Issuer's ordinary shares on the Nasdaq Stock Market LLC on September 4, 2026. The number of ordinary shares reported herein includes (i) 20,367 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 272,659 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
13,215 |
| 2026-09-07 | Tonucci Paolo |
See Remarks |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents the number of ordinary shares withheld to satisfy the tax withholding obligation in connection with the vesting of shares underlying the Issuer's 2022 Annual Long Term Incentive Plan. The price reported represents the closing price of the Issuer's ordinary shares on the Nasdaq Stock Market LLC on September 4, 2026. The number of ordinary shares reported herein includes (i) 20,628 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
18,293 |
| 2026-09-07 | Lowitt Ian T |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents the number of ordinary shares withheld to satisfy the tax withholding obligation in connection with the vesting of shares underlying the Issuer's 2022 Annual Long Term Incentive Plan. The price reported represents the closing price of the Issuer's ordinary shares on the Nasdaq Stock Market LLC on September 4, 2026. The number of ordinary shares reported herein includes (i) 41,256 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
36,587 |
| 2026-09-07 | Jethwa Nilesh |
CEO, Marex Solutions |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
Represents the number of ordinary shares withheld to satisfy the tax withholding obligation in connection with the vesting of shares underlying the Issuer's 2022 Annual Long Term Incentive Plan. The price reported represents the closing price of the Issuer's ordinary shares on the Nasdaq Stock Market LLC on September 4, 2026. The number of ordinary shares reported herein includes (i) 35,596 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 111,183 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
31,567 |
| 2026-08-19 | Jethwa Nilesh |
CEO, Marex Solutions |
Award↑
Filing footnotes — Ordinary Shares (Direct)
On September 6, 2023, the Reporting Person was granted an award under the Issuer's 2022 Annual Long Term Incentive Plan (the "Plan"), which vests in the form of ordinary shares subject to (i) performance conditions, including a minimum return on equity underpin and growth in adjusted operating profit before tax, and (ii) continued service through the third anniversary of the grant date, in each case subject to the terms of the Plan. On August 19, 2026, the Remuneration Committee of the Issuer's Board of Directors determined that the performance conditions had been met. The award remains subject to time-based vesting and will fully vest on September 6, 2026. The number of ordinary shares reported herein includes (i) 67,163 shares vesting under the Issuer's 2022 Annual Long Term Incentive Plan as described in footnote 1, and (ii) 111,183 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
67,163 |
| 2026-08-19 | Tonucci Paolo |
See Remarks |
Award↑
Filing footnotes — Ordinary Shares (Direct)
On September 6, 2023, the Reporting Person was granted an award under the Issuer's 2022 Annual Long Term Incentive Plan (the "Plan"), which vests in the form of ordinary shares subject to (i) performance conditions, including a minimum return on equity underpin and growth in adjusted operating profit before tax, and (ii) continued service through the third anniversary of the grant date, in each case subject to the terms of the Plan. On August 19, 2026, the Remuneration Committee of the Issuer's Board of Directors determined that the performance conditions had been met. The award remains subject to time-based vesting and will fully vest on September 6, 2026. The number of ordinary shares reported herein includes (i) 38,921 shares vesting under the Issuer's 2022 Annual Long Term Incentive Plan as described in footnote 1, and (ii) 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
38,921 |
| 2026-08-19 | Van Den Born Simon |
President |
Award↑
Filing footnotes — Ordinary Shares (Direct)
On September 6, 2023, the Reporting Person was granted an award under the Issuer's 2022 Annual Long Term Incentive Plan (the "Plan"), which vests in the form of ordinary shares subject to (i) performance conditions, including a minimum return on equity underpin and growth in adjusted operating profit before tax, and (ii) continued service through the third anniversary of the grant date, in each case subject to the terms of the Plan. On August 19, 2026, the Remuneration Committee of the Issuer's Board of Directors determined that the performance conditions had been met. The award remains subject to time-based vesting and will fully vest on September 6, 2026. The number of ordinary shares reported herein includes (i) 33,582 shares vesting under the Issuer's 2022 Annual Long Term Incentive Plan as described in footnote 1, and (ii) 272,659 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
33,582 |
| 2026-08-19 | Lowitt Ian T |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Ordinary Shares (Direct)
On September 6, 2023, the Reporting Person was granted an award under the Issuer's 2022 Annual Long Term Incentive Plan (the "Plan"), which vests in the form of ordinary shares subject to (i) performance conditions, including a minimum return on equity underpin and growth in adjusted operating profit before tax, and (ii) continued service through the third anniversary of the grant date, in each case subject to the terms of the Plan. On August 19, 2026, the Remuneration Committee of the Issuer's Board of Directors determined that the performance conditions had been met. The award remains subject to time-based vesting and will fully vest on September 6, 2026. The number of ordinary shares reported herein includes (i) 77,843 shares vesting under the Issuer's 2022 Annual Long Term Incentive Plan as described in footnote 1, and (ii) 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
77,843 |
| 2026-08-14 | Irvin Rob |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.71 to $72.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
200 |
| 2026-08-14 | Irvin Rob |
Director, Chief Financial Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.69 to $71.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
3,500 |
| 2026-08-10 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.17 to $62.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
3,963 |
| 2026-08-10 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.16 to $62.265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
455 |
| 2026-08-10 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.105 to $61.1, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
12,250 |
| 2026-07-13 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $63.645 to $64.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
11,850 |
| 2026-07-13 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.66 to $65.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
8,957 |
| 2026-07-13 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.66 to $66.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
787 |
| 2026-07-13 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.65 to $65.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
4,584 |
| 2026-07-13 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $63.66 to $64.6533, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
27,398 |
| 2026-07-13 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.715 to $65.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
232 |
| 2026-06-15 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.965 to $62.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
14,199 |
| 2026-06-15 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.945 to $63.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
809 |
| 2026-06-15 | Tonucci Paolo |
See Remarks |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.945 to $61.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
1,658 |
| 2026-06-12 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.81 to $62.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Ordinary Shares
|
32,813 |
| 2026-06-12 | Lowitt Ian T |
Director, Chief Executive Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.81 to $63.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
4,330 |
| 2026-06-09 | Schweinitz Konstantin Graf von |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
2,070 |
| 2026-06-09 | Pietrowicz John W. |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
2,070 |
| 2026-06-09 | Myers Linda Kristine |
Director |
Award↑
Filing footnotes — Ordinary Shares (Direct)
The number of ordinary shares reported herein includes 2,070 shares underlying restricted share awards granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award. |
Ordinary Shares
|
2,070 |